Cue Biopharma's total assets for Q3 2024 were $44.81M, an increase of 5.86% from the previous quarter. CUE total liabilities were $19.44M for the fiscal quarter, a -6.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.